Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669200 · ClinicalTrials.gov registry record · NA
Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment
A NA study of Mild Cognitive Impairment, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT01669200: Completed NA study of Mild Cognitive Impairment, sponsored by Pennington Biomedical Research Center.
NCT01669200 is a NA study of Mild Cognitive Impairment that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 4 participants, below the 1,271-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01669200, a NA study of Mild Cognitive Impairment, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to assess whether daily dosing with medium chain triglycerides in subjects with mild cognitive impairment (MCI) will improve cognitive performance.
Primary Outcome
Daily dosing of in subjects with Medium Chain Triglyceride Oil will change cognition scores measured at baseline to the end of week 24 using cognitive testing results. (ADAS-Cog, Trails Making Test, Mini Mental State Exam, Digit Symbol Test and Short-Form 36 Health Survey).
Conditions Studied
Interventions
- OTHER Medium Chain Triglyceride Oil
- OTHER Placebo Oil
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-10 |
| Phase | NA |
What the finished NCT01669200 record still lists
NCT01669200 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,271-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 2 interventions - of which Medium Chain Triglyceride Oil is the first listed.
NCT01669200 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT01669200 about?
NCT01669200 is a clinical study titled "Effect of Medium Chain Triglyceride Oil Supplementation in Mild Cognitive Impairment". The primary aim of this study is to assess whether daily dosing with medium chain triglycerides in subjects with mild cognitive impairment (MCI) will improve cognitive performance.
What is the current status of trial NCT01669200?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2012-08. Estimated completion is 2014-10.
What conditions does trial NCT01669200 study?
This clinical trial studies the following conditions: Mild Cognitive Impairment.
What interventions are being tested in trial NCT01669200?
The interventions under investigation include: Medium Chain Triglyceride Oil (OTHER), Placebo Oil (OTHER).
Who is sponsoring clinical trial NCT01669200?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01669200 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mild Cognitive Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01669200's enrollment target sits among peer trials
4 204th of 205 higher than 1 of 205 other Mild Cognitive Impairment trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Wayfinding Intervention and Long-Term Memory
RECRUITING · NA
-
Dual Task Perturbation Training for OAwMCI
RECRUITING · NA
-
Impact of Intensive Computerized Cognitive Training
RECRUITING · NA
-
Multimodal Investigation of Neural Plasticity
RECRUITING · NA
-
GAMES Intervention in MCI (Mild Cognitive Impairment)
RECRUITING · NA
-
A Feasiblity Study of Green Activity Program for People Living With Memory Challenges
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia